Stockscreener 앱 받기
6.19
9.56%
0.54
시장 영업 전:
6.14
-0.05
-0.81%
Aspire Biopharma Holdings Inc 주식(ASBP)의 최신 뉴스
Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue - ACCESS Newswire
ASBP Falls As Aspire Biopharma Bets $30M On Auto Deal - timothysykes.com
LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff? - Stocktwits
Aspire Biopharma Holdings, Inc. Files Form 8-K With SEC Detailing Other Events and NASDAQ Listing - Minichart
Trending Stocks Today | Aspire Biopharma up 6.03% Post-Market - Moomoo
Aspire Biopharma adjourns shareholder meeting due to lack of quorum - Investing.com UK
Aspire Biopharma adjourns shareholder meeting due to lack of quorum By Investing.com - Investing.com India
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
ASBP Jumps As Aspire Biopharma Attracts High-Volume Trading - timothysykes.com
Aspire Biopharma Stock Chops After Volatile Spike - StocksToTrade
ASBP - Finviz
ASBP Stock Draws Trader Focus As Volatility Spikes - StocksToTrade
Aspire Biopharma Holdings (ASBP) Stock: Slides After $30M DCS Acquisition Deal - parameter.io
Aspire Biopharma to Acquire Dura Driver Control Systems - TipRanks
Aspire Biopharma to Acquire FireFish Driver Control Systems Business for $30 Million, Plus Adjustments - TradingView
Aspire Biopharma Acquires Automotive Supplier Dura Driver Control Systems in $30M Deal (ASBP) - Yahoo Finance
ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier? - TradingView
Aspire Biopharma Stock Is Sliding Today: What's Going On? - Benzinga
Aspire Biopharma signs definitive SPA to acquire Dura Driver Control Systems - TipRanks
Aspire Biopharma to acquire auto parts maker for $30 million - Investing.com
Aspire Biopharma Agrees to Acquire Dura Driver Control Systems for $30 Million; Shares Surge Pre-Bell - marketscreener.com
Aspire Biopharma to acquire auto parts maker for $30 million By Investing.com - Investing.com Canada
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - GoUpstate
Aspire Biopharma Holdings Warrant (ASBPW) Remains Under Pressure at $0.02Fast Moving Stocks - newsline.com
Aspire Biopharma Issues Shareholder Letter - ACCESS Newswire
ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill
Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members - ACCESS Newswire
Aspire Biopharma Surges 18% as Bullish Momentum Builds Toward Key ResistanceVolume Nodes - newsline.com
Aspire Biopharma announces $5m share buyback, DCS acquisition By Investing.com - Investing.com India
Aspire Biopharma announces $5m share buyback, DCS acquisition - Investing.com UK
Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empow - The National Law Review
Aspire Biopharma Faces Sharp Decline, Testing Key Support LevelsSector Neutral Pair - thelegaladvocate.com
Aspire’s Buzz Bomb partners with EoS Fitness gym chain - Investing.com UK
Aspire’s Buzz Bomb partners with EoS Fitness gym chain By Investing.com - Investing.com South Africa
Under-the-tongue caffeine sticks to reach EoS gym members - Stock Titan
User - The Chronicle-Journal
Aspire Biopharma Company Profile & Introduction - Moomoo
Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - The Destin Log
Aspire Biopharma Holdings Warrants (ASBPW) Languish at Penny Level as Support and Resistance ConvergeHull Moving Average - newsline.com
Aspire Biopharma Holdings Warrant (ASBPW) Holds Steady at $0.02 – Minimal Price Action ContinuesRectangle Pattern - newsline.com
Why Kulicke And Soffa Industries Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - Sahm
ASBP Financials: Income Statement, Balance Sheet & Cash Flow | Aspire Biopharma Holdings Inc - Stock Titan
Aspire Biopharma Holdings, Inc. 1Q 2026: Revenue $28.35K, Net loss $(3.22M), EPS $(20.57) — 10-Q Summary - TradingView
Aspire Biopharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
1.27%
1.43%
자본화:
|
볼륨(24시간):